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Abstract
Alzheimer’s disease (AD) is the most prevalent form of dementia affecting the elderly. Neurodegeneration is caused by the
amyloid beta (Ab) peptide which is generated from the sequential proteolytic cleavage of the Amyloid Precursor Protein
(APP) by the b– and c- secretases. Previous reports revealed that the 37 kDa/67 kDa laminin receptor (LRP/LR) is involved in
APP processing, however, the exact mechanism by which this occurs remains largely unclear. This study sought to assess
whether LRP/LR interacted with APP, b- or c-secretase. Detailed confocal microscopy revealed that LRP/LR showed a strong
co-localisation with APP, b- and c-secretase, respectively, at various sub-cellular locations. Superresolution Structured
Illumination Microscopy (SR-SIM) showed that interactions were unlikely between LRP/LR and APP and b-secretase,
respectively, while there was strong co-localisation between LRP/LR and c-secretase at this 80 nm resolution. FRET was
further employed to assess the possibility of protein-protein interactions and only an interaction between LRP/LR and c-
secretase was found. FLAG co-immunoprecipitation confirmed these findings as LRP/LR co-immunoprecipitated with c-
secretase, but failed to do so with APP. These findings indicate that LRP/LR exerts its influence on Ab shedding via a direct
interaction with the c-secretase and possibly an indirect interaction with the b-secretase.
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Introduction
Alzheimer’s Disease (AD) is the most prevalent neurodegener-
ative disorder affecting the elderly population worldwide. There
are an estimated 37 million people suffering from this disease [1]
and due to the lack of any effective therapies, this number
continues to rise and pose more of an economic and social burden
[2]. Lack of understanding of the disease causing mechanisms have
resulted in great difficulties in the development of effective
therapeutic interventions and as yet, the only treatment strategies
are merely palliative, despite numerous ongoing clinical trials [3].
The two hallmark features of AD are the formation of
extracellular amyloid beta (Ab) plaques and intracellular neuro-
fibrillary tangles composed of hyperphosphorylated tau protein.
Oligomeric Ab is thought to be the candidate etiological agent for
AD since it has been found to mediate neurotoxicity through
interactions with many other proteins [4,5]. One such protein that
has proved to be of significance in AD is the cellular prion protein
(PrPc).
PrPc is thought to have a neuroprotective role with regard to
apoptosis and oxidative stress and also functions in cell signaling as
well as synapse physiology [6]; however, recent reports suggest an
important role for PrPc in mediating the toxicity caused by the Ab
peptide in AD. Lauren et al. showed that PrPc acts as a high affinity
receptor for Ab peptides and thus mediates the impairment of
synaptic plasticity [7]. Recently reports have further verified these
findings by showing that PrPc was required for the neurotoxicity
caused by Ab, through impairment of long term potentiation
(LTP) [8], as well as by regulating the function of the N-methyl-D-
aspartate receptor (NMDAR) – a function which is hindered due
to the Ab - PrPc interaction and leads to excessive activity of the
receptor thereby promoting neuronal damage [9]. PrPc has also
been implicated in neurotoxic signalling upon interaction with Ab
whereby Fyn kinase is activated and leads to dendritic spine loss,
lactate dehydrogenase activation and altered NMDAR expression
on the plasma membrane of neurons [10,11].
The cellular receptor for both PrPc [12] and its infectious
isoform PrPSc [13] is the 37 kDa/67 KDa Laminin Receptor
(LRP/LR). This multifunctional receptor has numerous physio-
logical roles including cell adhesion, migration, survival and
proliferation (for reviews see [14,15]). These roles are exploited by
neoplastic cells whereby the receptor is involved in tumour
metastasis [16,17,18,19], apoptosis [20] and angiogenesis [21].
Due to its role as the receptor for PrPc, we examined whether
LRP/LR may play some role in AD pathways. Blockage of LRP/
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LR with an anti-LRP/LR antibody (IgG1-iS18) or knock down of
LRP/LR using anti-LRP shRNAs resulted in a significant
reduction both in Ab levels [22] and Ab induced cytotoxicity
[23]. As expression of APP, b- and c-secretase were not affected
upon antibody or shRNA treatment, an interaction between LRP/
LR and one or more of the AD related proteins (APP, b- and c-
secretase) was deemed likely [22]. Since sAPPb shedding was also
impaired upon IgG1-iS18 and shRNA treatment, an interaction
between LRP/LR and b-secretase was examined and co-
immunoprecipitation revealed the existence of a (direct or indirect)
interaction between the 2 proteins [22]. These findings revealed a
novel role for LRP/LR in AD. We thus aimed to further
investigate whether LRP/LR interacts with the proteins which are
central to AD, namely APP, b- and c-secretase using high
resolution imaging.
Materials and Methods
Cell Culture and transient transfection
HEK293 cells were grown in Dulbecco’s modified Eagle’s
medium (DMEM) (Hyclone) supplemented with 10% fetal calf
serum (FCS) (Hyclone) and 1% Penicillin/Streptomycin. IMR-32
human neuroblastoma cells were cultivated in MEM (Hyclone)
supplemented with 10% FCS, 1% Penicillin/Streptomycin, 1%
Non-Essential Amino Acids and 2 mM L-glutamine. Cells were
incubated at 37uC with 5% CO2. The HEK293 cell line was
obtained from American Tissue Culture Collection (ATCC) while
IMR-32 cells were obtained from the Fox Chase Cancer Centre.
For transfections, cells were seeded onto sterile coverslips within
the wells of a 6 well tissue culture dish (Corning) for all
microscopy. For co-immunoprecipitation, HEK293 cells were
seeded into 60 mm tissue culture dishes (Corning). Once the cells
were 30–50% confluent, calcium phosphate transfection was
performed as described previously [22] for HEK293 cells while
TransITH-LT1 transfection reagent (Mirus) was used for the
transfection of the IMR-32 cells (in accordance with the
manufacturer’s instructions). The procedure for the generation
of the plasmids encoding LRP-dsRed (pLRP-dsRed) [24] and
LRP::FLAG (pCIneo-moLRP::FLAG) [25] has been described
previously. Plasmids for APP-GFP (pEGFPN1-APP770) and
BACE1-GFP (pEGFPN1-BACE1) [26] were a generous gift from
Dr. Bradley T Hyman, while pEGFP-PS1 (coding for PS1-GFP)
[27] was a kind gift from Dr. Oskana Berezovska. For confocal
microscopy, pLRP-dsRed was co-transfected with pEGFPN1-
APP770, pEGFPN1-BACE1 and pEGFP-PS1 respectively in a 1:1
ratio. pEGFP-N1 (Clonetech) and pDsRed-Express N1 (Clone-
tech) were used as controls. For co-immunoprecipitation, pCIneo-
moLRP::FLAG, pEGFPN1-APP770 and pEGFP-PS1 were indi-
vidually transfected into HEK293 cells in 60 mm tissue culture
dishes and incubated for 72 hours, after which the cells were lysed
for further experiments.
Slide preparation
24 hours post transfection, coverslips containing adherent
transfected cells (LRP-dsRed with APP-GFP, BACE1-GFP or
PS1-GFP) were washed with PBS 3 times and then fixed with 4%
Paraformaldehyde in PBS for 15 minutes. Coverslips were washed
with PBS and mounted onto clean microscope slides using 75 ml
Fluoromount (Sigma Aldrich). Slides were maintained at room
temperature for 1–2 hours in the dark to allow the mounting
medium to set.
Confocal Microscopy
Slides were viewed using the Zeiss LSM 780 confocal
microscope equipped with a GaAsp detector and images were
acquired through Z-stack acquisition, with an increment of
60.4 mm (depending on sample) between image frames. The
AxioCam MRm camera was utilized to capture images. Cells
expressing both LRP-dsRed and either APP-GFP, BACE1-GFP or
PS1-GFP were selected and Z-stack acquisition was performed.
Images were displayed as maximum intensity projections and
subsequently analysed for co-localisation using 2D cytofluoro-
grams and fluorescence intensity line profiles obtained with the use
of Zen 2010 imaging software.
SR-SIM Imaging
Slides were prepared as described and superresolution struc-
tured illumination (SR-SIM) was performed. Thin (0.1 mm) Z-
stacks of high-resolution image frames were collected in 5 rotations
by utilizing an alpha Plan-Apochromat 1006/1.46 oil DIC M27
ELYRA objective, using an ELYRA S.1 (Carl Zeiss Microima-
ging) microscope equipped with a 488 nm laser (100 mW),
561 nm laser (100 mW) and Andor EM-CCD camera (iXon
DU 885). Images were reconstructed using ZEN software (black
edition, 2011, version 7.04.287) based on a structured illumination
algorithm [28]. Analysis was performed on reconstructed super-
resolution images in ZEN.
FRET imaging
Cells were seeded onto coverslips, transfected as described
above and Fluorescence Resonance Energy Transfer (FRET)
acquisition and analysis was performed. Image frames were
collected using confocal microscopy (LSM 780, Carl Zeiss)
equipped with a LSM780 GaAsP detector, using a Plan-
Apochromat 636/1.4 Oil DIC M27 objective. Samples were
excited with a 488 nm and 561 nm laser under utilization of a
MBS 488/561 beam splitter. Emission was collected for the donor-
GFP channel at an emission window of 495 nm–510 nm, the
FRET channel at an emission window of 586 nm–600 nm and the
acceptor-dsRed channel at an emission window of 586 nm–
600 nm, using the lambda setting. Appropriate controls for
background, donor spectral bleed-through (DSB) and Acceptor
spectral bleed-through (ASB) were prepared and GFP only control
images as well as dsRed only control images were acquired.
Sensitized emission FRET analysis was performed utilizing
FRET_plus Version 3 for ZEN 2010. FRET (N-FRET, normal-
ized, Xia) data were generated, correcting for emission/excitation
crosstalk and normalizing for the concentration of donor and
acceptor. N-FRET was calculated using the Zeiss FRET plug-in
for HEK293 cells, while the Image-J FRET plug-in was utilized
for the IMR-32 cells, hence the slight differences in the
appearance of the FRET signals in the images.
FLAG Co-immunoprecipitation
HEK293 cells were utilized for this study as they share many
similarities and features with neuronal cells [29]. Only HEK293
cells were subjected to co-immunoprecipitation due to ease of
transfection. Cells transfected with pCIneo-moLRP::FLAG,
pCDNA3.1APPwt or pEGFP-PS1 were lysed 72 hours post-
transfection. Cell lysates from cells expressing LRP::FLAG were
mixed with those expressing either APP-GFP or PS1-GFP. Lysates
were subjected to a FLAG Co-immunoprecipitation assay (Sigma-
Aldrich) according to the manufacturer’s instructions and results
were analysed via immunoblotting.
Interactions between LRP/LR and AD Proteins
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Immunoblotting
Co-immunoprecipitation assay eluates were assessed using
immunoblotting. LRP::FLAG was detected using anti-FLAG
(mouse monoclonal IgG antibody) (1:5000) (Sigma-Aldrich) and
Anti-mouse HRP antibody (1:5000) (Sigma-Aldrich). APPwt was
detected using a rabbit monoclonal (Y188) antibody to Amyloid
beta Precursor Protein (Abcam) (1:3000) and PS1-GFP was
detected using rabbit monoclonal (EP2000Y) antibody against
Presenillin 1 (Abcam) (1:3000). An anti-rabbit HRP antibody
(1:5000) (Sigma-Aldrich) was employed for the detection of the
rabbit primary antibodies. Immunodetection was performed with
SuperSignal West Pico Chemiluminescent Substrate and X-ray
film (both Thermo Scientific).
Results and Discussion
Interactions between c-secretase and LRP/LR
c-secretase is composed of 4 sub-units namely Presenilin 1 or 2
(PS1 or PS2), nicastrin, anterior pharynx defective 1 and
presenilin enhancer 2 [30]. The presenilin proteins form the
catalytic domain of the c-secretase complex as they contain two
aspartyl residues, within transmembrane domains 6 and 7, which
are responsible for the c-secretase cleavage of APP [31]. The 4
Figure 1. LRP/LR co-localises with PS1 of the c-secretase complex. (A) Co-localisation between PS1-GFP and LRP-dsRed is shown for HEK293
cells in the maximum intensity profile for PS1-GFP and LRP-dsRed. The 2D cytofluorogram confirms co-localisation as a diagonal is observed passing
through quadrant 3. A diagonal is indicative of a high degree of co-localisation. Line profile displaying the fluorescence intensities of the 2 colour
channels along a line of interest and reveals co-localisation occurring specifically within the cytoplasmic regions. Line profile reveals aligned spectra
suggestive of high degree of co-localisation. (B) SR-SIM reveals that PS1-GFP and LRP-dsRed show a high degree of co-localisation in HEK293 cells. A
diagonal passes through quadrant 3 of the 2D cytofluorogram suggesting that there is still a high degree of co-localisation between the 2 proteins at
this resolution (80 nm). Scale bar: 5 mm. (C) SR-SIM reveals that co-localisation between LRP-dsRed and PS1-GFP is maintained in IMR-32 cells,
although the 2D cytofluorogram is skewed by the differences in transfectability with the different plasmids. Scale bars: 5 mm.
doi:10.1371/journal.pone.0100373.g001
Interactions between LRP/LR and AD Proteins
PLOS ONE | www.plosone.org 3 June 2014 | Volume 9 | Issue 6 | e100373
subunit complex is found to function predominantly within
cholesterol- and sphingolipid-rich lipid raft microdomains of
membranes, most notably those of the plasma membrane [32],
trans-Golgi Network (TGN) as well as endosomes [33]. The
cellular localisations of LRP/LR are limited to these same regions
and the presence of this protein has also been noted in the Golgi
apparatus [34]. The co-localisation observed from the maximum
intensity projection between PS1-GFP and LRP-dsRed supports
Figure 2. LRP/LR interacts with PS1 of the c-secretase complex. (A)(i) FRET analysis with PS1-GFP donor and LRP-dsRed acceptor in HEK293
cells. Distinct FRET signal is detected on the normalized FRET scale. Scale bar: 20 mm. (ii) Enlarged view of single cell from (i) showing that energy is
transferred in the cytoplasmic and plasma membrane regions of the cell. (iii) Enlarged view from cell in (i) showing FRET signal occurs in perinuclear
membrane. (B) FRET analysis between PS1-GFP donor and LRP-dsRed acceptor performed on IMR-32 cells. Blue FRET signal is detected in the
normalised FRET panel indicating an interaction is present between the two proteins. Scale bar: 5 mm. (C) FLAG co-immunoprecipitation assay was
performed utilizing lysates of HEK293 cells transfected with LRP::FLAG and PS1-GFP. Immunoblot performed using rabbit monoclonal antibody
(EP2000Y) for Presenillin 1. Lane (1) Non transfected cell lysates, (2) cell lysates expressing GFP alone, (3) cell lysates expressing PS1-GFP, (4) FLAG co-
immunoprecipitation eluate of assay performed using cell lysates expressing LRP::FLAG and PS1-GFP. Detected bands are 36 kDa indicating PS1
dimers and not PS1-GFP.
doi:10.1371/journal.pone.0100373.g002
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the notion that LRP/LR and c-secretase appear to be located in
similar cellular regions and compartments in HEK293 cells
(Figure 1A). The 2D cytofluorogram accompanying the maxi-
mum intensity projection shows a clear diagonal passing through
quadrant 3, indicating a high degree of co-localisation between
the signal in the green and red channels which results in the
observed yellow pattern of co-localisation. The line profile
obtained from the maximum intensity projection of the Z-stack
analysis between PS1-GFP and LRP-dsRed (Figure S1 in File S1)
reveals that the spectra are well aligned and fluorescence intensity
is strongest in the cytoplasm and plasma membrane. Due to the
limited resolving power dictated by the wavelength utilized in
laser scanning confocal microscopy, co-localisation does not
necessitate functional protein – protein interactions. This can in
part be overcome by an SR-SIM approach, which provides a
resolution limit of approximately 80 nm (compared to the
200 nm resolution limit of laser scanning microscopy). Figure 1B
reveals that even when SR-SIM is employed, a high degree of co-
localisation is still maintained between these two proteins,
suggesting that these proteins are indeed in close proximity to
one another in HEK293 cells. The expression of both PS1-GFP
and LRP-dsRed is even more distinctly defined within the
cytoplasm and on the plasma membrane when observed at this
resolution. Figure 1C illustrates that co-localisation between PS1-
GFP and LRPdsRed is also maintained in the IMR-32 cells in
similar subcellular locations as in the HEK293 cells. The lack of a
clear diagonal in the 2D cytofluorogram is as a result of differing
transfectability of the cells depicted in the image. As indicated,
only one of the cells was successfully co-transfected with both
PS1-GFP and LRPdsRed and this is where co-localisation is most
evident. In order to further assess whether this co-localisation is
due to protein-protein interactions, Fo¨rster Resonance Energy
Transfer (FRET) was employed as in this technique, the donor
and acceptor have to be within a proximity of 1–10 nm to induce
FRET. A well defined FRET signal is observed in the normalized
FRET scale panel (Figure 2A (i)), strongly suggesting protein-
protein interaction, and not only co-localisation between c-
secretase and LRP/LR. This interaction appears to take place
primarily in the cytoplasm and membrane region as revealed by
the FRET signal distribution pattern, clearly observed in
Figure 3. b-secretase fails to co-localise with LRP/LR at high resolutions. (A) Maximum intensity profile obtained from Z-stack analysis
reveals strong cytoplasmic co-localisation between BACE1-GFP and LRP-dsRed in HEK293 cells. Diagonal in 2D cytofluorogram indicates high degree
of co-localisation, as is confirmed by the line profile. (B) SR-SIM analysis of HEK293 cell expressing BACE1-GFP and LRP-dsRed. No co-localisation
occurs between these proteins. The 2D cytofluorogram confirms the absence of co-localisation as there is no signal detected in quadrant 3. Scale bar:
5 mm. (C) SR-SIM employing IMR-32 cells reveals a lack of co-localisation between LRPdsRed and BACE1-GFP. Scale bars: 5 mm.
doi:10.1371/journal.pone.0100373.g003
Interactions between LRP/LR and AD Proteins
PLOS ONE | www.plosone.org 5 June 2014 | Volume 9 | Issue 6 | e100373
Figure 2A (ii), which shows a close up of the FRET signal
obtained within an individual cell. LRP/LR and PS1 may be also
interacting in the perinuclear region of the cell, shown in
Figure 1C (iii). Furthermore, FRET was also observed in IMR-32
cells as indicated by the blue FRET signals observed in the
normalised FRET panel of Figure 2B, confirming the likelihood
of an interaction between PS1 and LRP. Based on these results, it
is highly likely that a direct interaction does exist between LRP/
LR and the PS1 subunit of the c-secretase. In order to validate
this, FLAG co-immunoprecipitation was performed using
LRP::FLAG and PS1-GFP (Figure 1D) in HEK293 cells. PS1 is
clearly detected in the FLAG co-immunoprecipitation assay
eluate, denoting that PS1 has bound to LRP::FLAG (Figure 1D,
lane 4). PS1 was detected within all of the control lanes, thus the
protein visualized is certainly cellular PS1 and not PS1-GFP. The
band is seen at 36 kDa which confirms that the proteins detected
are most likely the homo-dimer of PS1 [35,36], as the expected
band size for PS1 is 18 kDa. This co-immunoprecipitation
finding further substantiates the FRET data by confirming the
interaction between LRP/LR and PS1. These findings also
suggest an explanation for the altered APP processing observed
upon the blockage and knockdown of LRP/LR [22], as these
treatments may be interfering in or hampering the interaction
between LRP/LR and c-secretase. Further investigation is
required to determine the binding sites involved in the interaction
between these two proteins, in order to elucidate the role of the
interaction between LRP/LR and PS1 in the context of AD
pathology.
Interactions between b-secretase and LRP/LR
b-secretase (also known as BACE1 - b-site APP cleaving
enzyme) is a transmembrane aspartic protease which is predom-
inantly localised in the Golgi and trans-Golgi network (TGN), as
well as in endosomes, where a slightly acidic pH provides the
optimal environment for APP cleavage [37]. Initial reports
suggested not only co-localisation between LRP/LR and b-
secretase on the cell surface, but also that these two proteins
interacted, as shown by co-immunoprecipitation [22]. The
findings presented in Figures 3 and 4 help to further understand
the nature of the possible interactions between b-secretase and
LRP/LR, where the maximum intensity projection (Figure 3A)
constructed from Z-stack images (Figure S2 in File S1) shows
strong co-localisation between the 2 proteins within the cellular
cytoplasm – this most likely occurring in the endosomes. This is
further corroborated by the line profile in which the lines
representing the intensity of BACE1-GFP and LRP-dsRed are
not only aligned, but also show the highest fluorescence intensities
within the cytoplasm. However, when SR-SIM was employed, co-
localisation was lost between LRP/LR and b-secretase, implying
the proteins are situated approximately 100–200 nm from each
other in both HEK293 (Figure 3B) and IMR-32 cells (Figure 3C).
This diminishes the likelihood of a direct interaction between these
two proteins, due to the spatial separation observed. The FRET
findings further confirm this, as no FRET occurred between the
BACE1-GFP donor and the LRP-dsRed acceptor within both the
HEK293 and IMR-32 cells (Figure 4A and B respectively). These
findings infer that the interaction that was reported between LRP/
Figure 4. b-secretase doesn’t interact with LRP/LR as revealed by FRET analysis. (A) FRET did not occur between the donor BACE1-GFP and
the acceptor LRP-dsRed in HEK293 cells as no signal was detected on the normalized FRET scale. Scale bar: 20 mm. (B) Similarly, a lack of interaction
was detected between LRPdsRed and BACE1-GFP when IMR-32 cells were used. Scale bars:10 mm.
doi:10.1371/journal.pone.0100373.g004
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LR and b-secretase [22] is most likely an indirect interaction
mediated by another cellular protein, as whole cell lysates were
employed for co-immunoprecipitation studies. LRP/LR and b-
secretase share several binding/interaction partners, the most
notable one being PrPc [38,39]. It is possible that since LRP/LR is
the cellular receptor for PrPc and plays an important role in
regulating endocytosis [40] and propagation [41] of PrPc, it may
indirectly influence b-secretase activity. Another factor that may
have led to the co-immunoprecipitation between LRP::FLAG and
b-secretase is heparan sulphate proteoglycan (HSPG). Binding
sites for HSPG have been located on LRP/LR and are implicated
in regulating the interaction between LRP/LR and PrPc [42].
Extensive studies have been performed on heparan sulphate, and
analogues thereof, as therapeutic options for Alzheimer’s Disease.
Most notably this proteoglycan is seen to regulate b-secretase
activity and significantly reduce the shedding of Ab [43,44,45].
Thus, HSPG is another molecule which could be responsible for
the indirect interaction suggested by the co-immunoprecipitation
observed between LRP/LR and b-secretase [22], as it interacts
with both of these proteins. PrPc and HSPG could also be
responsible for the decrease in sAPPb (the cleavage product of b-
secretase) levels upon anti-LRP/LR antibody and shRNA
treatment [22] since they may be directly affected by these
treatments, resulting in an indirect effect on b-secretase activity
which they are seen to regulate.
Interactions between APP and LRP/LR
Initially, an interaction between LRP/LR and APP seemed
highly likely and would provide an explanation for the effects seen
on Ab shedding upon antibody and shRNA treatment of LRP/LR
[22]. Initial findings also suggested that these two proteins co-
localise when detected on non-permeabilised cells (indicating cell
surface co-localisation) and within the cells (indicating intracellular
co-localisation) [22]. Z-stacking was performed to further verify
the sub-cellular localisations of these proposed interactions and to
assess whether they were maintained throughout the cell (Figure
S3 in File S1). Maximum intensity projections were constructed
from the images obtained via Z-stacking and revealed a degree of
overlap between the LRP-dsRed with APP-GFP signal as
indicated by the resulting yellow colour when the images are
Figure 5. Co-localisation occurs between APP and LRP/LR. (A) Maximum intensity profile obtained from Z-stack analysis revealing co-
localisation between APP-GFP and LRP-dsRed in the cytoplasm of HEK293 cells. 2D cytofluorogram reveals the co-distribution of green (APP-GFP) and
red (LRP-dsRed) pixels. (B) SR-SIM analysis reveals that APP-GFP and LRP-dsRed co-localise to a lesser extent in HEK293 cells. Co-localisation is highest
at the cell surface and in limited cytoplasmic locations. Scale bar: 10 mm. (C) Similar co-localisation is observed in IMR-32 cells. Scale bar: 5 mm.
doi:10.1371/journal.pone.0100373.g005
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merged (Figure 5A). The line profile constructed from the
maximum intensity projection of the Z-stack between APP-GFP
and LRP-dsRed, shows the intensity of the red and green
fluorescence along the line passing through the HEK293 cell of
interest. These findings suggest a complete spatial overlap between
the fluorescence observed in both the green and red channels. The
observed intensity of both fluorescent channels is highest in the
cytoplasm which further confirms the initial assumption that
LRP/LR and APP are located in similar cellular locations.
Findings in literature further support these data as it is known that
APP is transported to the plasma membrane, where it is
subsequently endocytosed from lipid raft regions into early
endosomes [46,47]. Moreover, LRP/LR is known to also be
located in the lipid raft [48] as well as in early endosomes [40].
Our SR-SIM data indicates a lower degree of co-localisation
between APP and LRP both in HEK293 (Figure 5B) and IMR-32
cells (Figure 5C), which appears to be confined to the plasma
membrane and certain cytoplasmic regions, presumably the
endosomes in which both APP and LRP/LR are localised. This
suggests the proteins are indeed in close proximity to one another,
resulting in the distinct co-localisation pattern. FRET was
employed to further assess the viability of an interaction between
LRP/LR and APP. This analysis revealed that no FRET occurred
between APP-GFP and LRP-dsRed, since signal detection was
lacking on the normalized FRET scale for both HEK293
(Figure 6A) and IMR-32 cells (Figure 6B). These findings indicate
that no interaction takes place between APP and LRP/LR at this
1–10 nm scale. FLAG Co-immunoprecipitation using a FLAG
Figure 6. APP-GFP and LRP/LR fail to interact. FRET was performed using APP-GFP as donor and LRP-dsRed as acceptor in HEK293 cells. No
FRET signal was observed on the normalized FRET scale indicating that no energy transfer occurred from BACE1-GFP to LRPdsRed. Scale bar: 20 mm.
(B) Similarly, no FRET was observed between APP-GFP and LRPdsRed in IMR-32 cells. Scale bar: 10 mm. (C) FLAG co-immunoprecipitation analysis
using lysates of HEK293 cells expressing LRP::FLAG and APPwt. Anti-APP antibody (Y188) was utilised for detection. Lane (1) cell lysates containing
LRP::FLAG, (2) cell lysate with overexpressed APPwt (APP positive control), (3) FLAG co-immunoprecipitation assay eluate of assay performed using
APPwt overexpressing cell lysates but no LRP::FLAG (i.e. Anti-FLAG M2 bead binding control), (4) BAP fusion protein (positive control for FLAG co-
immunoprecipitation assay), (5) empty lane, (6) FLAG co-immunoprecipitation assay eluate of sample with LRP::FLAG and APPwt, (7–9) Wash fractions
1–3 of APPwt+LRP::FLAG FLAG co-immunoprecipitation assay post overnight binding step.
doi:10.1371/journal.pone.0100373.g006
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PLOS ONE | www.plosone.org 8 June 2014 | Volume 9 | Issue 6 | e100373
tagged LRP/LR variant (LRP::FLAG) further confirmed these
results as APP was not detected in the eluate of the assay
(Figure 6C, lane 6). The results obtained from figure 3 collectively
suggest that although LRP/LR and APP are found in similar
cellular locations in which they co-localise, the proximity between
them is still present when SR-SIM is employed (i.e. 80 nm), but
lost at the nanometer scale required for FRET to take place, thus
indicating that it is highly unlikely for any interaction to occur
between these two proteins.
Interactions between GFP and LRP/LR
GFP was used a negative control for these studies as it failed to
co-localise with LRP/LR. This is evidenced by the maximum
intensity projection (Figure 7A) obtained from Z-stack analysis
(Figure S4 in File S1). The 2D cytofluorogram reveals a complete
absence of a diagonal passing through quadrant 3 confirming the
lack of co-localisation between GFP and LRP-dsRed. The line
profile obtained shows two distinct patterns of fluorescence lacking
any co-alignment of the red and green channels further confirming
the low degree of co-localisation between these proteins. These
findings also validate the co-localisation seen between LRP and
APP, b- and c-secretase, as the observed co-localisation is as a
result of the proximity of LRP/LR to the AD proteins and not
simply due to the GFP labels.
Conclusions
In light of this study, we have found that LRP/LR is seen to co-
localise with APP, b- and c-secretase both on the cell surface and
intracellularly within the cytoplasm. This co-localisation is limited
to 200 nm when observed for BACE1 and LRP/LR, to 80 nm
between APP and LRP/LR and less than 10 nm for LRP/LR and
PS1. These results reveal a novel interaction between LRP/LR
and the PS1 catalytic subunit of the c-secretase complex (as
confirmed by co-immunoprecipitation) and suggest that the
previously observed interaction between LRP/LR and BACE1 is
likely an indirect interaction only. These findings cumulatively
highlight the role of LRP/LR in Alzheimer’s Disease.
Supporting Information
File S1 Contains Figures S1–S4. Figure S1, Z-stack analysis
of co-localisation between PS1-GFP and LRP-dsRed. Figure S2,
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tained by z-stack analysis. Figure S3, Z-stack analysis of APP-GFP
and its co-localisation with LRP-dsRed. Figure S4, lack of co-
localisation between GFP and LRP-dsRed as evidenced by z-stack
analysis.
(DOCX)
Acknowledgments
We would like to acknowledge Dr. Bradley T Hyman (Harvard Medical
School, Massachusetts, USA) for his generous gift of pEGFPN1-APP770
and pEGFPN1-BACE1. We also acknowledge Dr. Oksana Berezovska
(Massachusetts General Hospital, Massachusetts) for the kind gift of
pEGFP-PS1.
Author Contributions
Conceived and designed the experiments: SFW. Performed the experi-
ments: KJ BL. Analyzed the data: KJ BL BDD. Contributed reagents/
materials/analysis tools: CP. Wrote the paper: KJ. Edited the manuscript:
SFW BDD.
References
1. Mount C, Downton C (2006) Alzheimer disease: progress or profit? Nat Med 12:
780–784.
2. Wimo A, Jonsson L, Bond J, Prince M, Winblad B (2013) The worldwide
economic impact of dementia 2010. Alzheimers Dement 9: 1–11 e13.
3. Mangialasche F, Solomon A, Winblad B, Mecocci P, Kivipelto M (2010)
Alzheimer’s disease: clinical trials and drug development. Lancet Neurol 9: 702–
716.
4. Kudo W, Lee HP, Zou WQ, Wang X, Perry G, et al. (2012) Cellular prion
protein is essential for oligomeric amyloid-beta-induced neuronal cell death.
Hum Mol Genet 21: 1138–1144.
5. Verdier Y, Penke B (2004) Binding sites of amyloid beta-peptide in cell plasma
membrane and implications for Alzheimer’s disease. Curr Protein Pept Sci 5:
19–31.
6. Westergard L, Christensen HM, Harris DA (2007) The cellular prion protein
(PrP(C)): its physiological function and role in disease. Biochim Biophys Acta
1772: 629–644.
7. Lauren J, Gimbel DA, Nygaard HB, Gilbert JW, Strittmatter SM (2009) Cellular
prion protein mediates impairment of synaptic plasticity by amyloid-beta
oligomers. Nature 457: 1128–1132.
8. Barry AE, Klyubin I, Mc Donald JM, Mably AJ, Farrell MA, et al. (2011)
Alzheimer’s disease brain-derived amyloid-beta-mediated inhibition of LTP in
vivo is prevented by immunotargeting cellular prion protein. J Neurosci 31:
7259–7263.
9. You H, Tsutsui S, Hameed S, Kannanayakal TJ, Chen L, et al. (2012) Abeta
neurotoxicity depends on interactions between copper ions, prion protein, and
N-methyl-D-aspartate receptors. Proc Natl Acad Sci U S A 109: 1737–
1742.
Figure 7. LRP/LR fails to co-localise with GFP. (A) Maximum intensity projection obtained from Z-stack analysis of GFP and LRP-dsRed shows
poor co-localisation between the 2 proteins. This is further confirmed by the lack of a clear diagonal passing through quadrant 3 and the line profile
which shows no alignment between the 2 colour channels.
doi:10.1371/journal.pone.0100373.g007
Interactions between LRP/LR and AD Proteins
PLOS ONE | www.plosone.org 9 June 2014 | Volume 9 | Issue 6 | e100373
10. Um JW, Strittmatter SM (2013) Amyloid-beta induced signaling by cellular
prion protein and Fyn kinase in Alzheimer disease. Prion 7: 37–41.
11. Um JW, Nygaard HB, Heiss JK, Kostylev MA, Stagi M, et al. (2012) Alzheimer
amyloid-beta oligomer bound to postsynaptic prion protein activates Fyn to
impair neurons. Nat Neurosci 15: 1227–1235.
12. Gauczynski S, Peyrin JM, Haik S, Leucht C, Hundt C, et al. (2001) The 37-
kDa/67-kDa laminin receptor acts as the cell-surface receptor for the cellular
prion protein. EMBO J 20: 5863–5875.
13. Gauczynski S, Nikles D, El-Gogo S, Papy-Garcia D, Rey C, et al. (2006) The 37-
kDa/67-kDa laminin receptor acts as a receptor for infectious prions and is
inhibited by polysulfated glycanes. J Infect Dis 194: 702–709.
14. Mbazima V, Da Costa Dias B, Omar A, Jovanovic K, Weiss S (2010)
Interactions between PrPc and other ligands with the 37-kDa/67-kDa laminin
receptor. Frontiers in Bioscience 15: 1150–1163.
15. Omar A, Jovanovic K, Da Costa Dias B, Gonsalves D, Moodley K, et al. (2011)
Patented biological approaches for the therapeutic modulation of the 37 kDa/
67 kDa laminin receptor. Expert Opin Ther Pat 21: 35–53.
16. Chetty C, Khumalo T, Da Costa Dias B, Reusch U, Knackmuss S, et al. (2014)
Anti-LRP/LR Specific Antibody IgG1-iS18 Impedes Adhesion and Invasion of
Liver Cancer Cells. PLoS One 9: e96268.
17. Zuber C, Knackmuss S, Zemora G, Reusch U, Vlasova E, et al. (2008) Invasion
of tumorigenic HT1080 cells is impeded by blocking or downregulating the 37-
kDa/67-kDa laminin receptor. J Mol Biol 378: 530–539.
18. Omar A, Reusch U, Knackmuss S, Little M, Weiss SF (2012) Anti-LRP/LR-
specific antibody IgG1-iS18 significantly reduces adhesion and invasion of
metastatic lung, cervix, colon and prostate cancer cells. J Mol Biol 419: 102–109.
19. Khumalo T, Reusch U, Knackmuss S, Little M, Veale RB, et al. (2013)
Adhesion and Invasion of Breast and Oesophageal Cancer Cells Are Impeded
by Anti-LRP/LR-Specific Antibody IgG1-iS18. PLoS One 8: e66297.
20. Moodley K, Weiss SF (2013) Downregulation of the non-integrin laminin
receptor reduces cellular viability by inducing apoptosis in lung and cervical
cancer cells. PLoS One 8: e57409.
21. Khusal R, Da Costa Dias B, Moodley K, Penny C, Reusch U, et al. (2013) In
vitro inhibition of angiogenesis by antibodies directed against the 37 kDa/
67 kDa laminin receptor. PLoS One 8: e58888.
22. Jovanovic K, Gonsalves D, Da Costa Dias B, Moodley K, Reusch U, et al.
(2013) Anti-LRP/LR specific antibodies and shRNAs impede amyloid beta
shedding in Alzheimer’s disease. Sci Rep 3: 2699.
23. Da Costa Dias B, Jovanovic K, Gonsalves D, Reusch U, Knackmuss S, et al.
(2013) Anti-LRP/LR specific antibody IgG1-iS18 rescues cells from Ab42
induced cytotoxicity. Scientific Reports 3: 2702.
24. Nikles D, Vana K, Gauczynski S, Knetsch H, Ludewigs H, et al. (2008)
Subcellular localisation of prion proteins and the 37 kDa/67 kDa laminin
receptor fused to fluorescent proteins. Biochim Biophys Acta 1782: 335–340.
25. Vana K, Weiss S (2006) A trans-dominant negative 37 kDa/67 kDa laminin
receptor mutant impairs PrP(Sc) propagation in scrapie-infected neuronal cells.
J Mol Biol 358: 57–66.
26. von Arnim CA, Tangredi MM, Peltan ID, Lee BM, Irizarry MC, et al. (2004)
Demonstration of BACE (beta-secretase) phosphorylation and its interaction
with GGA1 in cells by fluorescence-lifetime imaging microscopy. J Cell Sci 117:
5437–5445.
27. Uemura K, Lill CM, Li X, Peters JA, Ivanov A, et al. (2009) Allosteric
modulation of PS1/gamma-secretase conformation correlates with amyloid
beta(42/40) ratio. PLoS One 4: e7893.
28. Heintzmann R, Cremer CG (1999) Laterall modulated excitation microscopy:
improvement of resolution by using a diffraction grating. In: Bigio IJ,
Schneckenburger H, Slavik J, Svanberg K, Viallet PM, editors. SPIE digital
Library. pp. 185–196.
29. Shaw G, Morse S, Ararat M, Graham FL (2002) Preferential transformation of
human neuronal cells by human adenoviruses and the origin of HEK 293 cells.
FASEB J 16: 869–871.
30. Edbauer D, Winkler E, Regula JT, Pesold B, Steiner H, et al. (2003)
Reconstitution of gamma-secretase activity. Nat Cell Biol 5: 486–488.
31. Wolfe MS, Xia W, Ostaszewski BL, Diehl TS, Kimberly WT, et al. (1999) Two
transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis
and gamma-secretase activity. Nature 398: 513–517.
32. Chyung JH, Raper DM, Selkoe DJ (2005) Gamma-secretase exists on the
plasma membrane as an intact complex that accepts substrates and effects
intramembrane cleavage. J Biol Chem 280: 4383–4392.
33. Vetrivel KS, Cheng H, Lin W, Sakurai T, Li T, et al. (2004) Association of
gamma-secretase with lipid rafts in post-Golgi and endosome membranes. J Biol
Chem 279: 44945–44954.
34. Shmakov AN, Bode J, Kilshaw PJ, Ghosh S (2000) Diverse patterns of
expression of the 67-kD laminin receptor in human small intestinal mucosa:
potential binding sites for prion proteins? J Pathol 191: 318–322.
35. Schroeter EH, Ilagan MX, Brunkan AL, Hecimovic S, Li YM, et al. (2003) A
presenilin dimer at the core of the gamma-secretase enzyme: insights from
parallel analysis of Notch 1 and APP proteolysis. Proc Natl Acad Sci U S A 100:
13075–13080.
36. Herl L, Lleo A, Thomas AV, Nyborg AC, Jansen K, et al. (2006) Detection of
presenilin-1 homodimer formation in intact cells using fluorescent lifetime
imaging microscopy. Biochem Biophys Res Commun 340: 668–674.
37. Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA, et al. (1999) Beta-
secretase cleavage of Alzheimer’s amyloid precursor protein by the transmem-
brane aspartic protease BACE. Science 286: 735–741.
38. Parkin ET, Watt NT, Hussain I, Eckman EA, Eckman CB, et al. (2007) Cellular
prion protein regulates beta-secretase cleavage of the Alzheimer’s amyloid
precursor protein. Proc Natl Acad Sci U S A 104: 11062–11067.
39. Griffiths HH, Whitehouse IJ, Baybutt H, Brown D, Kellett KA, et al. (2011)
Prion protein interacts with BACE1 protein and differentially regulates its
activity toward wild type and Swedish mutant amyloid precursor protein. J Biol
Chem 286: 33489–33500.
40. Morel E, Andrieu T, Casagrande F, Gauczynski S, Weiss S, et al. (2005) Bovine
prion is endocytosed by human enterocytes via the 37 kDa/67 kDa laminin
receptor. Am J Pathol 167: 1033–1042.
41. Leucht C, Simoneau S, Rey C, Vana K, Rieger R, et al. (2003) The 37 kDa/
67 kDa laminin receptor is required for PrP(Sc) propagation in scrapie-infected
neuronal cells. EMBO Rep 4: 290–295.
42. Hundt C, Peyrin JM, Haik S, Gauczynski S, Leucht C, et al. (2001)
Identification of interaction domains of the prion protein with its 37-kDa/67-
kDa laminin receptor. EMBO J 20: 5876–5886.
43. Scholefield Z, Yates EA, Wayne G, Amour A, McDowell W, et al. (2003)
Heparan sulfate regulates amyloid precursor protein processing by BACE1, the
Alzheimer’s beta-secretase. J Cell Biol 163: 97–107.
44. Patey SJ, Yates EA, Turnbull JE (2005) Novel heparan sulphate analogues:
inhibition of beta-secretase cleavage of amyloid precursor protein. Biochem Soc
Trans 33: 1116–1118.
45. Beckman M, Holsinger RM, Small DH (2006) Heparin activates beta-secretase
(BACE1) of Alzheimer’s disease and increases autocatalysis of the enzyme.
Biochemistry 45: 6703–6714.
46. Schneider A, Rajendran L, Honsho M, Gralle M, Donnert G, et al. (2008)
Flotillin-dependent clustering of the amyloid precursor protein regulates its
endocytosis and amyloidogenic processing in neurons. J Neurosci 28: 2874–
2882.
47. Ehehalt R, Keller P, Haass C, Thiele C, Simons K (2003) Amyloidogenic
processing of the Alzheimer beta-amyloid precursor protein depends on lipid
rafts. J Cell Biol 160: 113–123.
48. Patra SK, Rizzi F, Silva A, Rugina DO, Bettuzzi S (2008) Molecular targets of
(-)-epigallocatechin-3-gallate (EGCG): specificity and interaction with membrane
lipid rafts. J Physiol Pharmacol 59 Suppl 9: 217–235.
Interactions between LRP/LR and AD Proteins
PLOS ONE | www.plosone.org 10 June 2014 | Volume 9 | Issue 6 | e100373
